MCSTAP Case Discussion Series: Care of Perinatal Patients with Substance Use Disorder: Applying an Evidence-Based, Person-Centered Approach - November 14, 2025

This site is for learners who attended the live November 14, 2025, program to claim credit.

Claiming Credit 

Thank you for participating in this program. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to complete the evaluation and claim your credit on the following page.

ADA statement: To request reasonable accommodations for a disability please contact [email protected], in writing, at least two weeks prior to the activity.

Target Audience

Primary care physicians, internists, family practice physicians, nurse practitioners, nurses, and physician assistants

Learning Objectives

Upon completion of this activity, participants will be able to:
  • Describe best practices for initial management of medications for psychiatric and substance use disorder treatment in pregnancy
  • Summarize rationale behind universal trauma precautions in perinatal patients with SUD with their patients
  • Describe complexities of toxicology testing in perinatal space

 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 1.00 MA Opioid Education Statement
  • 1.00 Participation
Course opens: 
11/14/2025
Course expires: 
12/15/2025
Rating: 
0
Zoom
United States
Christopher Shanahan, MD, MPH, FACP
MCSTAP Medical Director, CME Course Director
 

Faculty

Jessica Gray, MD

Polina Teslyar, MD

 
BU CCE Operations Manager: Naomi Moeller

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program meets the criteria of the Massachusetts Board of Registration in Medicine for 1 hour of opioid education.

 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 1.00 MA Opioid Education Statement
  • 1.00 Participation
Please login or register to take this course.